avalynpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Home - Avalyn Pharma |
| Description | Targeted therapies for rare lung Avalyn Pharma Inc About Leadership Board of Directors Investors Timeline Therapeutic Focus Overview Inhaled Advantage Publications Pipeline Overview AP01 |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 151.101.65.195 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
avalynpharma.com Valuation
|
US$8,105,186
Last updated: 2023-05-11 12:25:27
avalynpharma.com has Semrush global rank of 1,305,868. avalynpharma.com has an estimated worth of US$ 8,105,186, based on its estimated Ads revenue. avalynpharma.com receives approximately 935,214 unique visitors each day. Its web server is located in United States, with IP address 151.101.65.195. According to SiteAdvisor, avalynpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$8,105,186 |
| Daily Ads Revenue | US$7,482 |
| Monthly Ads Revenue | US$224,452 |
| Yearly Ads Revenue | US$2,693,416 |
| Daily Unique Visitors | 62,348 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| avalynpharma.com. | A | 3599 | IP: 151.101.65.195 |
| avalynpharma.com. | A | 3599 | IP: 151.101.1.195 |
| avalynpharma.com. | NS | 3600 | NS Record: ns60.domaincontrol.com. |
| avalynpharma.com. | NS | 3600 | NS Record: ns59.domaincontrol.com. |
| avalynpharma.com. | MX | 3600 | MX Record: 0 avalynpharma-com.mail.protection.outlook.com. |
| avalynpharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:avalynpharma.onmicrosoft.com -all |
| avalynpharma.com. | TXT | 3600 | TXT Record: google-site-verification=uMCznBGUN0027fqrNlggVcdPnd6MLLzl44EOuhUNERA |
HtmlToTextCheckTime:2023-05-11 12:25:27
| Avalyn Pharma Inc About Leadership Board of Directors Investors Timeline Therapeutic Focus Overview Inhaled Advantage Publications Pipeline Overview AP01 AP02 AP02-DP AP03 AP04 AP0X Patients Overview Expanded Access News & Events News Events Careers Overview Open Positions Contact Targeted therapies for rare lung diseases About Us Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases , including idiopathic pulmonary fibrosis and other interstitial lung diseases. Our lead candidate, AP01, is a Phase 2b-ready inhaled formulation of pirfenidone in development for the treatment of pulmonary fibrosis. Therapeutic Focus Avalyn is developing inhaled formulations of approved medications to treat rare respiratory diseases. Our initial focus is on the treatment of Interstitial Lung Diseases , including Idiopathic Pulmonary Fibrosis, and rare diseases that have dramatic impacts on patient quality of life. News < May 10, 2023 |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Varnish Retry-After: 0 Location: https://avalynpharma.com/ Content-Length: 0 Accept-Ranges: bytes Date: Thu, 04 Nov 2021 18:19:10 GMT Connection: close X-Served-By: cache-chi21168-CHI X-Cache: HIT X-Cache-Hits: 0 X-Timer: S1636049950.239218,VS0,VE0 HTTP/2 301 location: https://www.avalynpharma.com/ content-type: text/plain; charset=utf-8 accept-ranges: bytes date: Thu, 04 Nov 2021 18:19:10 GMT x-served-by: cache-chi21155-CHI x-cache: MISS x-cache-hits: 0 x-timer: S1636049950.292937,VS0,VE20 vary: x-fh-requested-host, accept-encoding content-length: 44 HTTP/2 200 cache-control: max-age=3600 content-type: text/html; charset=utf-8 etag: "465c5ccc1a5ab5227b380476b1712a2b774ef5a4ade93e1fdf89fc2892c98d81" last-modified: Fri, 28 May 2021 17:46:25 GMT link: ;rel=preload;as=script,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=script,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=script,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document,;rel=preload;as=document strict-transport-security: max-age=31556926 accept-ranges: bytes date: Thu, 04 Nov 2021 18:19:10 GMT x-served-by: cache-chi21175-CHI x-cache: MISS x-cache-hits: 0 x-timer: S1636049950.382759,VS0,VE124 vary: x-fh-requested-host, accept-encoding content-length: 27980 |
avalynpharma.com Whois Information
Domain Name: AVALYNPHARMA.COM Registry Domain ID: 2137609643_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-04-22T17:42:51Z Creation Date: 2017-06-27T17:04:33Z Registry Expiry Date: 2022-06-27T17:04:33Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS59.DOMAINCONTROL.COM Name Server: NS60.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-29T06:04:02Z <<< |